Risk factors for subclinical endometritis and its effect on reproductive performance in small-scale dairy farms

亚临床子宫内膜炎的风险因素及其对小型奶牛场繁殖性能的影响

阅读:2

Abstract

The study aimed to evaluate the effect of subclinical endometritis (SCE) on reproductive performance and identify risk factors for this pathology in small-scale dairies. In four small-scale dairies, 608 lactations were monitored for health issues, nutritional status, and reproductive events, and SCE was diagnosed based on endometrial polymorphonuclear counting (PMN%) at 30±5 (SCE30) and 60±5 (SCE60) days postpartum. The threshold for diagnosis was established according to the quartile distribution of PMN%; 4 % and 2 % for SCE30 and SCE60. Conception rate at first service (CRFS), number of services per conception (SC), and days open (DO) were analyzed for SCE effect through Chi-square or ANOVA. Events of interest were considered in each lactation to perform a risk factor analysis using univariate logistic regression and multiple logistic regression model building. The population attributable fraction was calculated to identify the most important risk factors. Considering both sampling periods, 40.5 % of the cows were positive for SCE. SCE30-positive cows had lower CRFS (38.9 vs 53.7 %), required 0.4 more SC, and had 20.2 more DO than SCE30-negative cows (P ≤ 0.001). SCE60-positive cows had 16 more DO than SCE60-negative cows (P ≤ 0.01). The most important risk factors for SCE30 were retained fetal membranes (RFM) and uterine diseases, while calving season, RFM, and SCE30 status were the risk factors for SCE60. SCE could represent a major problem in small-scale dairies due to its prevalence and negative effect on reproductive performance. Furthermore, there are identifiable risk factors for SCE under these production conditions, which should be considered when designing prevention strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。